Key Dates

Related Announcements

• June 25, 2025 - NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00 Clinical Trial Not Allowed).  See NOFO PAR-25-333. 
• April 24, 2024 - NIH Pathway to Independence Award (Parent K99/R00 - Independent Clinical Trial Required). See NOFO PA-24-193.
• April 24, 2024 - NIH Pathway to Independence Award (Parent K99/R00 - Independent Clinical Trial Not Allowed). See NOFO PA-24-194.
• April 24, 2024 - NIH Pathway to Independence Award (Parent K99/R00 Independent Basic Experimental Studies with Humans Required). See NOFO PA-24-195. 
• July 13, 2024 - NINDS Alzheimer's Disease-Related Dementias (ADRD) Advanced Postdoctoral Career Transition Award (K99/R00 Independent Clinical Trial Not Allowed). See NOFO PAR-24-213

Issued by

Office of The Director, National Institutes of Health (OD)

Purpose

By way of this Notice, the National Institutes of Health (NIH) announces a short-term automatic eligibility extension for prospective applicants to the NIH Pathway to Independence Award (K99/R00) program. This extension is being granted in response to disruptions caused by the recent lapse in federal appropriations and is intended to lessen the impact of these disruptions on application submission, peer review, and award processing.

This extension is limited to individuals whose eligibility period under the Parent K99/R00 would have ended between September 2025 – November 2025.

Who Is Impacted

This Notice provides K99/R00 eligibility extensions for the following prospective applicants:

• Individuals whose final due date for new/resubmission applications (based on a 48-month eligibility window) was September-November 2025. The last submission with K99/R00 eligibility will be February/March 2026.
• Individuals whose final due date for new/resubmission applications (based on a 48-month eligibility window) was January-March 2026. The last submission with K99/R00 eligibility will be June/July 2026.

Please note that this eligibility extension applies to AIDS dates for the above receipt cycles.

Implementation

The eligibility extension listed in this Notice applies only to potential submissions under the following  Notices of Funding Opportunities (NOFO)  (PA-24-193, PA-24-194, PAR-24-213, PA-24-195, and  PAR-25-333).

For eligible applicants submitting new or re-submission applications, an extension will be automatically accepted by the NIH. However, prospective K99 applicants who wish to receive extensions for personal or family situations (see Eligible Individuals under Section III of PA-24-193, PA-24-194, or PA-24-195) must continue to provide relevant documentation to the NIH Institute or Center to which their application will be submitted. While multiple extensions for overlapping events are not typically permitted, this Notice will not be considered overlapping with other already approved qualifying events. Please contact program official(s) at the NIH Institute or Center to which the application will be submitted for further guidance. 

Inquiries

Please direct all inquiries to:

Prospective applicants should direct inquiries related to their specific circumstances to the NIH Institute or Center to which their application will be submitted.

General inquiries about this policy should be directed to:

Division of Biomedical Research Workforce
Office of Extramural Research
National Institutes of Health
Email: [email protected]